Clinical Trials Browser

Phase NA × Capecitabine × Tumor-Agnostic × Clear all

NCT01295086 2020-11-02

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

Phase NA Completed

Adenocarcinoma

NCT04194957 2020-01-22

Alpe2U

Phase NA Unknown

Neoplasms

NCT02324452 2018-05-11

Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines

Phase NA Completed

Neoplasms